Katie Lyday

Regulatory Affairs Specialist at StimLabs
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
Atlanta, Georgia, United States, GE

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

You need to have a working account to view this content.
You need to have a working account to view this content.

Credentials

  • Introduction to Regulatory Submissions in the eCTD Format
    Regulatory Affairs Professionals Society (RAPS)
    Mar, 2021
    - Nov, 2024
  • Basic Life Support for Healthcare Providers (BLS)
    American Red Cross
    Jan, 2021
    - Nov, 2024
  • APhA's Pharmacy-Based Immunization and Delivery: A Certificate Training Program for Pharmacists
    American Pharmaceutical Association (APhA)
    Jan, 2020
    - Nov, 2024
  • Regulator Sciences Certificate
    University of Georgia
    Jan, 2019
    - Nov, 2024
  • Clinical Trials Design and Management Certificate
    The University of Georgia
    Jan, 2018
    - Nov, 2024
  • Pharmacist
    Georgia Board of Pharmacy
    Jan, 2002
    - Nov, 2024

Experience

    • United States
    • Medical Equipment Manufacturing
    • 100 - 200 Employee
    • Regulatory Affairs Specialist
      • Aug 2021 - Present

    • Regulatory Affairs Consultant
      • May 2021 - Aug 2021

      Worked as a Regulatory Affairs Consultant for Project ALS • Developed a successful approach and strategy for the compounding and delivery of an investigational new drug in the clinic for a Phase I first in human clinical trial under an initial IND for Amyotrophic Lateral Sclerosis (ALS) • Successfully contributed to Drug Product sections of IND; no FDA potential clinical hold issues or significant comments were received from the Division of Neurology Products to open this IND Worked as a Regulatory Affairs Consultant for Project ALS • Developed a successful approach and strategy for the compounding and delivery of an investigational new drug in the clinic for a Phase I first in human clinical trial under an initial IND for Amyotrophic Lateral Sclerosis (ALS) • Successfully contributed to Drug Product sections of IND; no FDA potential clinical hold issues or significant comments were received from the Division of Neurology Products to open this IND

  • Stacy's Compounding Pharmacy
    • Greater Atlanta Area
    • Compounding Pharmacist
      • Nov 2018 - Aug 2021

      • Compounded medications into customized formulations including sterile products, customized flavored and concentrated suspensions, and topical delivery systems • Developed SOPs to ensure compliance with USP <795>, <797>, and <800> general chapters • Supervised students and technical staff in a busy compounding pharmacy • Compounded medications into customized formulations including sterile products, customized flavored and concentrated suspensions, and topical delivery systems • Developed SOPs to ensure compliance with USP <795>, <797>, and <800> general chapters • Supervised students and technical staff in a busy compounding pharmacy

    • United States
    • Biotechnology Research
    • 1 - 100 Employee
    • Regulatory Affairs Intern
      • Mar 2017 - Jul 2018

      SCOPE: Worked alongside the director of regulatory affairs in preparing regulatory dossiers for FDA submissions. ORGANIZATIONAL IMPACT: * Prepared submissions that included pre-IND meeting requests, BLAs, DMFs, amendments, supplements, and annual reports for GeoVax’s HIV vaccine candidates in partnership with the director. * Selected to draft module 1-4 content in traditional CTD format and eCTD format. SCOPE: Worked alongside the director of regulatory affairs in preparing regulatory dossiers for FDA submissions. ORGANIZATIONAL IMPACT: * Prepared submissions that included pre-IND meeting requests, BLAs, DMFs, amendments, supplements, and annual reports for GeoVax’s HIV vaccine candidates in partnership with the director. * Selected to draft module 1-4 content in traditional CTD format and eCTD format.

    • Consultant Pharmacist
      • 2012 - 2013

      SCOPE: Brought on board as the initial consultant in Georgia for a genetic testing start-up company. Onboarded new pharmacist consultants as the company experienced significant growth. ORGANIZATIONAL IMPACT:  Partnered with physicians and staff; offered clinical interpretations and insights related to genetic cytochrome P450 enzyme polymorphisms. Worked alongside sales representatives and provided advisement and support. * Visited sites; offered clinical support and advised sales representatives. Educated sales staff prior to client meetings. * Clearly explained the science behind genetic tests and demonstrated how the results related to and could impact patients taking medications prescribed by a physician. Show less

    • Hospitals and Health Care
    • 700 & Above Employee
    • Hospital Pharmacist
      • 2001 - 2004

      SCOPE: Adhered to quality standards while serving as an inpatient pharmacist at this university-based teaching hospital. ORGANIZATIONAL IMPACT: * Maintained accuracy in order entry, drug distribution, and therapeutic drug monitoring. * Collaborated with healthcare providers to ensure patients received optimal drug therapy. * Applied science behind the medication with a focus on achieving optimal drug therapy for each patient. SCOPE: Adhered to quality standards while serving as an inpatient pharmacist at this university-based teaching hospital. ORGANIZATIONAL IMPACT: * Maintained accuracy in order entry, drug distribution, and therapeutic drug monitoring. * Collaborated with healthcare providers to ensure patients received optimal drug therapy. * Applied science behind the medication with a focus on achieving optimal drug therapy for each patient.

    • United States
    • Hospitals and Health Care
    • 700 & Above Employee
    • Hospital Pharmacist
      • 1998 - 2001

      SCOPE: Met quality standards in inpatient pharmacy and IV room settings for this community hospital. Accurately performed order entry, drug distribution, and therapeutic drug monitoring. ORGANIZATIONAL IMPACT: * Worked in collaboration with healthcare staff to provide patients with optimal drug therapies. * Monitored and adjusted drug therapies based on patient responses. SCOPE: Met quality standards in inpatient pharmacy and IV room settings for this community hospital. Accurately performed order entry, drug distribution, and therapeutic drug monitoring. ORGANIZATIONAL IMPACT: * Worked in collaboration with healthcare staff to provide patients with optimal drug therapies. * Monitored and adjusted drug therapies based on patient responses.

    • United States
    • Hospitals and Health Care
    • 700 & Above Employee
    • Hospital Pharmacist
      • 1994 - 1998

      SCOPE: Worked primarily as an IV room pharmacist in a fast-paced environment. Gained in-depth experience in aseptic technique, including chemotherapy pediatrics, parenteral nutrition, and anesthesia. ORGANIZATIONAL IMPACT: * Aligned with quality standards in inpatient pharmacy and IV room settings for this community hospital. SCOPE: Worked primarily as an IV room pharmacist in a fast-paced environment. Gained in-depth experience in aseptic technique, including chemotherapy pediatrics, parenteral nutrition, and anesthesia. ORGANIZATIONAL IMPACT: * Aligned with quality standards in inpatient pharmacy and IV room settings for this community hospital.

Education

  • University of North Carolina at Chapel Hill
    Bachelor of Science - BS, Pharmacy
    1989 - 1994
  • The University of Georgia
    Master of Science - MS, Regulatory Affairs
    2016 - 2021

Community

You need to have a working account to view this content. Click here to join now